Valsartan Plaintiffs: Have You Considered Legal Funding?

Jacky Gale | December 13th, 2018

Since the initial discovery of carcinogenic contaminants in valsartan pills, which occurred in July 2018, the generic medication has been subjected to numerous recalls by the FDA. To date, the FDA has recalled valsartan from a handful of manufacturers, including Teva Pharmaceuticals, Prinston Pharmaceutical Inc., Actavis Inc., and Major Pharmaceuticals. At the end of November 2018, the FDA updated its recall list again after Teva Pharmaceuticals issued a voluntary recall for valsartan combination pills produced by Mylan India. These include amlodipine-valsartan combination pills and amlodipine-valsartan-hydrochlorothiazide combination pills.

Can legal funding help valsartan plaintiffs?

For patients who have taken these generic medications under the assumption that they were safe, it can feel like a betrayal of trust to learn that their medications may have been contaminated by cancer-causing N-nitrosodimethylamine (NDMA). Some lawsuits have already been filed by valsartan patients. While litigation is often the only viable avenue for pursuing justice, it can take months or years to resolve complicated disputes in court.

And in the meantime, valsartan plaintiffs may have trouble paying legal fees, medical bills, and everyday living expenses. One possible solution is applying for legal funding. Legal funding is different from bank or credit union loans. It’s more like a cash advance made against the promise of a future jury award or settlement. It’s also non-recourse. If you win your case or obtain a settlement, you’ll pay back the cash advance at a reasonable rate of interest. But if you lose your case, you’ll pay nothing—not a single dime. It’s a risk-free way of getting the cash you need now.

Why would valsartan plaintiffs need legal funding?

The litigation process is notoriously slow. Some lawsuits remain pending for years. And in the meantime, people injured by valsartan may have to deal with rising medical expenses. NDMA is known to cause cancer in humans, and cancer is one of the most expensive medical problems a person can have. There may be multiple rounds of chemotherapy, radiation therapy, surgical interventions, and supportive care. Even with great health insurance, it can be difficult to pay for all the bills. Plus, cancer patients may be unable to work. They may require full-time care by family members, and family caregivers may struggle to maintain employment while providing intensive care.

People with cancer deserve the best possible care, and legal funding can help them get it. And since there’s zero risk to you for applying for a lawsuit loan, there’s really nothing to lose. If approved, you can use the money to pay for anything you need, including legal fees, home health aides, medications, or durable medical equipment.

LawStreet Capital offers 24-hour approval on cash advances for future jury awards and settlements. We’re widely recognized as one of the industry leaders in legal funding, thanks to our transparent terms, low rates, and quick approval. We’re also a BBB-Accredited Business and a member of the American Legal Finance Association. Remember: There’s never any risk to you if you lose your case. Get the money you need now. Call LawStreet Capital toll-free at 888-557-1637.

Additional resources:

  1. U.S. Food & Drug Administration, FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity,
  2. Fortune, FDA Warns Sixth Valsartan Blood Pressure Drug Recalled for Contamination,